V. Schneider

Contribution of intracellular ATP to cisplatin resistance of tumor cells

U. Jaehde, G. V. Kalayda, G. Bendas, 2012, JBIC Journal of Biological Inorganic Chemistry.

Pharmacologic abrogation of the mitotic spindle checkpoint by an indolocarbazole discovered by cellular screening efficiently kills cancer cells.

Hongtao Yu, V. Schneider, H. Bastians, 2009, Cancer research.

Transporter-Mediated Interaction Between Platinum Drugs and Sorafenib at the Cellular Level

U. Jaehde, G. V. Kalayda, V. Schneider, 2017, The AAPS Journal.

Intracellular ATP depletion leads to reduced platinum accumulation in ovarian cancer cells.

U. Jaehde, G. V. Kalayda, G. Bendas, 2010, International journal of clinical pharmacology and therapeutics.

The use of vascular biomarkers and imaging studies in the early clinical development of anti‐tumour agents targeting angiogenesis

J. Drevs, V. Schneider, 2006, Journal of internal medicine.

Contribution of intracellular ATP to cisplatin resistance of tumor cells

U. Jaehde, G. Bendas, V. Schneider, 2013, JBIC Journal of Biological Inorganic Chemistry.

The CHK2–BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells

I. Petersen, W. Weichert, G. Dittmar, 2010, Nature Cell Biology.

Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.

Martin Koch, Ulrich Jaehde, U. Jaehde, 2010, International journal of pharmaceutics.

Transporter-Mediated Interaction Between Platinum Drugs and Sorafenib at the Cellular Level

U. Jaehde, V. Schneider, Selim Chaib, 2017, The AAPS Journal.